Combination Therapy With VELCADE and Tissue Plasminogen Activator Is Neuroprotective in Aged Rats After Stroke and Targets MicroRNA146a and the TollLike Receptor Signaling Pathway.

http://www.medworm.com/index.php?rid=6309978&cid=c_64_7_f&fid=33881&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2FPubMed%2F22723435%3Fdopt%3DAbstract

Comments are closed.